drug-eluting stent

(redirected from Drug-eluding stent)

drug-eluting stent

Abbreviation: DES
A stent coated with medications that it releases into surrounding intimal cells. It is designed to keep the lumen of an artery from closing both by holding the artery open and by retarding the growth of the vascular endothelium into the stent. See: bare metal stent
See also: stent
References in periodicals archive ?
It is the firm's drug-eluding stent program that has made its way into the newswires recently, as officials within the company recently pushed back their expected entry into the U.
He has brought his expertise in how aspects of drug-eluding stent design alleviate scaring by delivering medication to the specific stent site.
And you explore these trends and influences, among others: -- Effects of US excise tax on medical devices and their sellers -- Drug-eluding stents and other product development - R&D trends -- Transcatheter aortic valve replacement (TAVR) and other innovations -- Reducing the gap between cardiac devices and MRI scans -- Mergers and acquisitions - deals consolidating that medical industry.
Furthermore, both of these cases used drug-eluding stents on the LMCA disease.
They inserted three drug-eluding stents into the MP's left anterior descending artery.
The convergence of the medical device and drug industry has been positive in terms of development of improved products: drug-eluding stents and glucose monitoring systems incorporated into insulin pumps, etc.
There has been a growing body of evidence that drug-eluding stents, when compared to bare-metal stents, may increase the risk of blood clot formation long after they are implanted, potentially triggering a heart attack.
This market analysis does not include drug-eluding stents or prefilled or regular syringes.
Some of the pioneering efforts include: Only center in the Twin Cities to have implanted drug-eluding stents to prevent restenosis; One of only five centers in the world to be investigating intracoronary ultrasound to prevent restenosis; First center to implant the Symbion total artificial heart in Minnesota in a woman and child; First center to perform intracoronary radiation in the Twin Cities; One of the first double lung transplants in the U.
MIVT is developing a next-generation cardiovascular stent technology being designed to provide substantial health and safety benefits and outcomes over previous generations of drug-eluding stents.
MIVT is a leader in the development of next-generation cardiovascular stent technology being designed to provide substantial health and safety benefits and outcomes over previous generations of bare-metal and drug-eluding stents.